What are the changes in diagnosis of other specified schizophrenia spectrum and other psychotic disorders across Diagnostic and Statistical Manual of Mental Disorders (DSM) versions 3, 3-TR (Text Revision), 4, 5, and 5-TR (Text Revision), and International Classification of Diseases (ICD) versions 10 and 11?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evolution of "Other Specified Schizophrenia Spectrum and Other Psychotic Disorder" Across DSM and ICD Versions

Direct Answer

The most significant change is the shift from purely categorical classification in DSM-III/IV and ICD-10 to dimensional symptom assessment in DSM-5 and ICD-11, with both modern systems eliminating traditional schizophrenia subtypes and adding severity specifiers rated across six symptom domains. 1, 2

Major Structural Changes Across Versions

DSM-III and DSM-IV Era

  • DSM-III and DSM-IV maintained categorical diagnostic approaches with discrete subtypes of schizophrenia (paranoid, disorganized, catatonic, undifferentiated, residual) and separate categories for "psychotic disorder not otherwise specified" when presentations didn't fit established criteria 1, 3
  • The 6-month duration criterion for schizophrenia was established to differentiate it from briefer psychotic episodes, with "schizophreniform disorder" designated for presentations meeting schizophrenia criteria but lasting less than 6 months 2, 3
  • Diagnostic boundaries between different psychotic disorders were less precisely defined, leading to spurious comorbidity and diagnostic confusion 4

DSM-5 Revolution (2013)

  • DSM-5 eliminated all classic schizophrenia subtypes entirely and replaced them with dimensional symptom assessments, representing a fundamental reconceptualization of psychotic disorders 4, 5
  • Schneiderian first-rank symptoms lost their special diagnostic status and are no longer given preferential weight 4, 5
  • Schizoaffective disorder criteria were more precisely delineated from both schizophrenia and psychotic mood disorders to reduce diagnostic overlap 4
  • Catatonia was clarified as a specifier that can be applied consistently across multiple diagnostic categories rather than being limited to schizophrenia 4, 5
  • "Attenuated psychosis syndrome" was added to Section 3 as a condition for further study, representing prodromal or subthreshold psychotic presentations 4, 5

ICD-10 to ICD-11 Transition (2020)

  • ICD-11 restructured the entire mental disorders chapter, creating a unified "Schizophrenia or Other Primary Psychotic Disorders" grouping with dimensional symptom specifiers that can be applied to any diagnosis within this category 1, 2
  • Six symptom domains are now rated on a 4-point scale (not present to present and severe): positive symptoms, negative symptoms, depressive symptoms, manic symptoms, psychomotor symptoms, and cognitive symptoms 1, 2, 6
  • Course specifiers were added with two components: episodicity (first episode, multiple episodes, or continuous course) and current clinical status (currently symptomatic, partial remission, full remission) 1, 2
  • ICD-11 introduced transsectional diagnostic criteria for schizoaffective disorder, representing a fundamental reorganization of how this diagnosis is conceptualized 7, 8
  • Acute and transient psychotic disorders and delusional disorders underwent reorganization in ICD-11 8, 9

Harmonization Between DSM-5 and ICD-11

  • Both classification systems moved toward dimensional assessment and away from discrete subtypes, representing collaborative harmonization efforts between the American Psychiatric Association and World Health Organization 7, 6, 8
  • Despite harmonization goals, some differences remain in details and conceptual orientation, with complete alignment achieved only partially 8, 9
  • The dimensional approach in both systems allows rating symptom severity across multiple domains at each assessment, providing flexibility for treatment planning without requiring precise temporal calculations 7

Clinical Utility and Field Study Evidence

  • Field studies with 873 clinicians demonstrated that 82.5% to 83.9% rated ICD-11 as quite or extremely easy to use, accurate, clear, and understandable compared to ICD-10 7, 6
  • Interrater reliability for psychotic disorders was high in ICD-11 ecological field studies 7
  • Small but measurable improvements in diagnostic accuracy were documented using ICD-11 compared to ICD-10, though advantages were largely limited to new diagnostic categories 2, 7

Practical Implications for "Other Specified" Diagnoses

  • The "other specified" category now functions as a residual diagnosis when presentations don't meet criteria for established psychotic disorders but can be characterized dimensionally using the six symptom domain ratings 1, 2
  • Clinicians should document specific reasons why criteria for established disorders are not met while providing dimensional symptom profiles 1
  • Longitudinal reassessment is critical, as diagnoses frequently evolve over time—patients often present during acute psychosis before meeting duration criteria for definitive diagnoses 2, 7

Assessment Recommendations

  • Use structured diagnostic interviews (SCID-5 or MINI 7.0) rather than unstructured clinical assessment to reduce diagnostic bias and improve reliability 6
  • Create detailed life charts documenting the longitudinal course of symptoms to accurately determine temporal relationships and episodicity patterns 7, 6
  • Gather collateral information from family members and other observers, as patient insight may be limited during acute psychotic episodes 7
  • Document target symptoms at baseline and monitor treatment response systematically 1

Common Pitfalls to Avoid

  • Avoid premature definitive diagnosis during first presentations—many patients initially diagnosed with brief psychotic disorder or "other specified" presentations later meet criteria for schizophrenia as the 6-month duration threshold is reached 2
  • Don't rely solely on categorical diagnosis; the dimensional symptom profiles provide critical information for treatment planning that categorical labels alone cannot capture 1, 2
  • Recognize that complete recovery within 6 months is unusual for schizophrenia, as negative symptoms typically persist; this helps differentiate true brief psychotic episodes from early schizophrenia 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Evolution of Schizophreniform Disorder Diagnostic Criteria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Psychotic disorders in DSM-5: summary of changes.

Asian journal of psychiatry, 2013

Guideline

Psychotic Disorder Classification Changes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Schizoaffective Disorder Diagnostic Criteria Evolution

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Classifying psychosis--challenges and opportunities.

International review of psychiatry (Abingdon, England), 2012

Related Questions

What are the changes in diagnosis of specified schizophrenia spectrum and other psychotic disorders across Diagnostic and Statistical Manual of Mental Disorders (DSM) versions 3, 3-TR (Text Revision), 4, 5, and 5-TR (Text Revision), and International Classification of Diseases (ICD) versions 10 and 11?
What are the changes in the diagnosis of schizophrenia disorder across Diagnostic and Statistical Manual of Mental Disorders (DSM) (Diagnostic and Statistical Manual of Mental Disorders) versions 3, 4, 5, and 5-Text Revision (TR), and International Classification of Diseases (ICD) (International Classification of Diseases) versions 10 and 11?
What are the changes in diagnosis of other specified schizophrenia spectrum and other psychotic disorders across Diagnostic and Statistical Manual of Mental Disorders (DSM) versions 3, 3-TR (Text Revision), 4, 5, and 5-TR (Text Revision), and International Classification of Diseases (ICD) versions 10 and 11?
What are the changes in diagnosis of unspecified schizophrenia spectrum and other psychotic disorders across Diagnostic and Statistical Manual of Mental Disorders (DSM) versions 3, 3-TR (Text Revision), 4, 5, and 5-TR (Text Revision), and International Classification of Diseases (ICD) versions 10 and 11?
What are the changes in the diagnosis of Schizophreniform disorder across Diagnostic and Statistical Manual of Mental Disorders (DSM) (Diagnostic and Statistical Manual of Mental Disorders) 3, 4, 5, and 5-Text Revision (TR), and International Classification of Diseases (ICD) (International Classification of Diseases) 10 and 11?
What is the initial treatment guideline for a patient with severe Community-Acquired Pneumonia (CAP)?
What is the management approach for a patient with type 2 diabetes on tirzepatide (a dual GIP and GLP-1 receptor agonist) therapy who develops food poisoning?
Do Baclofen and Robaxin (Methocarbamol) cause drowsiness?
What is the preferred treatment, Robaxin (methocarbamol) or Baclofen, for a patient with spinal muscular pain, considering potential interactions with kidney or liver disease?
What is the management and treatment approach for a patient with chronic pancreatitis?
What is the management and treatment approach for a patient with chronic pancreatitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.